Premenstrual Syndrome Treatment Market by Product Type, Distribution Channel, End User 2023-2028

1
Global Premenstrual Syndrome Treatment Market
Research and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Premenstrual Syndrome Treatment Market
Research Report The latest report by IMARC,
titled Premenstrual Syndrome Treatment Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028 " finds that
the global online gambling market size reached
US 1,346 Million in 2022. Premenstrual
syndrome (PMS) treatment involves therapeutic
processes to alleviate emotional, physical, and
psychological symptoms that women experience,
including bloating, breast tenderness, body pain,
fatigue, mood swings, and anxiety. These symptoms
occur at the end of the luteal phase and subside
with menstruation or shortly thereafter. They are
often treated by antidepressants, analgesics,
nonsteroidal anti-inflammatory drugs (NSAIDs),
diuretics, ovarian suppression agents, and
hormonal contraceptives, which are available over
the counter or via prescription. Additionally,
novel PMS treatments, including topical gels,
creams, capsules, and suppositories, are also
used to manage mood imbalances, reduce uterine
cramps, and promote muscle relaxation. Request
Free Sample Report https//www.imarcgroup.com/pre
menstrual-syndrome-treatment-market/requestsample
4
Report Description and Highlights
Report Description

Global Premenstrual Syndrome Treatment Market
Trends The market is primarily driven by the
increasing prevalence of PMS and premenstrual
dysphoric disorder (PMDD) due to sedentary
lifestyles and hectic working schedules of the
female working population. In addition, rising
awareness among individuals regarding available
treatment solutions for PMS disorders represents
another major growth-inducing factor. Besides
this, individuals are adopting nutritional
supplements made with plant-based sources to
provide relief from PMS. These supplements
contain nutrients, such as calcium, potassium,
magnesium, and proteins, that aid in reducing
fatigue and easing anxiety and depression. This,
coupled with the introduction of smartphone
applications that records physiological and
emotional changes occurring in the body and sends
notification reminders for medication, is
positively influencing the market growth.
Moreover, the launch of advanced medications with
minimal side effects that aid in maintaining the
appropriate pH balance in the body is also
creating a favorable market outlook. Looking
forward, IMARC Group expects the market value to
reach US 1,683 Million by 2028, exhibiting a
CAGR of 3.9 during 2023-2028. Looking forward,
the market value is projected to reach a strong
growth during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Drug Type
Analgesics Antidepressants Ora
l Contraceptives and Ovarian Suppression Agents
Others Breakup by Type Presc
ription Over-the-Counter Breakup by Dis
tribution Channel Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores Breakup by Region
North America

6
Report Description and Highlights
Report Description
United States
Canada Asia-Pacific
China Japan
India South Korea
Australia Indo
nesia Others Europe
Germany France
United Kingdom
Italy Spain
Russia Others
Latin America Brazil

7
Report Description and Highlights
Report Description
Mexico Others
Middle East and Africa


8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• AbbVie Inc
• BASF SE Bayer AG Dr. Reddys Laboratories Ltd Eli
  Lilly and Company GlaxoSmithKline Plc. H. Lundbec
  k A/S
  Pfizer Inc. SHIONOGI Co. Ltd.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/premenstrual-syndrome-t
  reatment-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us